Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The cellular activity of several regulatory and signal transduction proteins, which depend on the Hsp90 molecular chaperone for folding, is markedly decreased by geldanamycin and by radicicol (monorden). We now show that these unrelated compounds both bind to the N-terminal ATP/ADP-binding domain of Hsp90, with radicicol displaying nanomolar affinity, and both inhibit the inherent ATPase activity of Hsp90 which is essential for its function in vivo. Crystal structure determinations of Hsp90 N-terminal domain complexes with geldanamycin and radicicol identify key aspects of their nucleotide mimicry and suggest a rational basis for the design of novel antichaperone drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
Self-citationDynamic activation of endothelial nitric oxide synthase by Hsp90
García-Cardeña, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo
Panaretou, B., Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4829 · Cited by 735
Self-citationGrenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H.-J., Schulte, T. W., Sausville, E., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23843 · Cited by 569
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
Supko, J. G., Hickman, R. L., Grever, M. R., & Malspeis, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689048 · Cited by 510
Joab, I., Radanyi, C., Renoir, M., Buchou, T., Catelli, M.-G., Binart, N., Mester, J., & Baulieu, E.-E. (1984) · Nature · doi:10.1038/308850a0 · Cited by 434
Research works printed but not linked: 15
- Kwon H. J., 1992, Biosci. Biotechnol. Biochem., 56, 539
- Zhao J. F., 1995, Oncogene, 11, 173
- Kwon H. J., 1995, J. Biochem., 118, 228
- Fukazawa H., 1991, Biochem. Pharmacol., 42, 1671
- Smith D. F., 1995, Mol. Cell. Biol., 15, 6812
- Whitesell L., 1996, Endocrinology, 10, 712
- Ali J. A., 1993, Biochemistry, 32, 2724
- Cutler H. G., 1987, Agric. Biol. Chem., 51, 3338
- Schnur R. C., 1995, J. Med. Chem., 38, 3820
- Schnur R. C., 1995, J. Med. Chem., 38, 3812
- Hartmann F., 1997, Int. J. Cancer, 70, 229, 10.1002/(SICI)1097-0215(19970117)70:2<221::AID-IJC14>3.0.CO;2-L · doi:10.1002/(sici)1097-0215(19970117)70:2<221::aid-ijc14>3.0.co;2-l
- Dai K., 1996, J. Biol. Chem., 271, 22034
- Whitesell L., 1992, Cancer Res., 52, 1728
- Prodromou C., 1996, PROTEINS: Struct. Funct. Genet., 25, 522
- Merrit E. A., 1994, Acta Crystallogr., 50, 873
Cited by
Items 201–300 of 1,000
Host cell factor requirement for hepatitis C virus enzyme maturation
Waxman, L., Whitney, M. A., Pollok, B. A., Kuo, L. C., & Darke, P. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241510898 · Cited by 93
Expanding the role of proteasome homeostasis in Parkinson’s disease: beyond protein breakdown
Bi, M., Du, X., Jiao, Q., Chen, X., & Jiang, H. F. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03441-0 · Cited by 99
Molecular Strategies to Target Protein Aggregation in Huntington’s Disease
Jarosińska, O. D., & Rüdiger, S. G. D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.769184 · Cited by 90
Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90
Barta, T. E., Veal, J. M., Rice, J. W., Partridge, J. M., Fadden, R. P., Ma, W., Jenks, M., Geng, L., Hanson, G. J., Huang, K. H., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.05.023 · Cited by 95
Hsp90: Friends, clients and natural foes
Verma, S., Goyal, S., Jamal, S., Singh, A. P., & Grover, A. (2016) · Biochimie · doi:10.1016/j.biochi.2016.05.018 · Cited by 99
To Fold or Not to Fold: Modulation and Consequences of Hsp90 Inhibition
Peterson, L. B., & Blagg, B. S. J. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.17 · Cited by 97
Kitson, R. R. A., Chang, C., Xiong, R., Williams, H. E. L., Davis, A. L., Lewis, W., Dehn, D. L., Siegel, D. M., Roe, S. M., Prodromou, C., et al. (2013) · Nature Chemistry · doi:10.1038/nchem.1596 · Cited by 91
Self-citationOn the Reach of Chemical Synthesis: Creation of a Mini‐Pipeline from an Academic Laboratory
Wilson, R. M., & Danishefsky, S. J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000775 · Cited by 88
Chen, F., Yu, Y., Qian, J., Wang, Y., Cheng, B., Dimitropoulou, C., Patel, V., Chadli, A., Rudic, R. D., Stepp, D. W., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300361 · Cited by 87
HSP90: a promising broad-spectrum antiviral drug target
Wang, Y., Jin, F., Wang, R., Li, F., Wu, Y., Kitazato, K., & Wang, Y. (2017) · Archives of Virology · doi:10.1007/s00705-017-3511-1 · Cited by 92
Fadden, P., Huang, K. H., Veal, J. M., Steed, P. M., Barabasz, A. F., Foley, B. E., Hu, M., Partridge, J. M., Rice, J. W., Scott, A., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.015 · Cited by 93
Gano, J. J., & Simon, J. A. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900261-mcp200 · Cited by 87
Gerges, N. Z., Tran, I. C., Backos, D. S., Harrell, J. M., Chinkers, M., Pratt, W. B., & Esteban, J. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0594-04.2004 · Cited by 85
Huai, Q., Wang, H., Liu, Y., Kim, H.-Y., Toft, D. O., & Ke, H. (2005) · Structure · doi:10.1016/j.str.2004.12.018 · Cited by 94
Bijlmakers, M.-J., & Marsh, M. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.5.1585 · Cited by 87
Giommarelli, C., Zuco, V., Favini, E., Pisano, C., Piaz, F. D., Tommasi, N. D., & Zunino, F. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0233-x · Cited by 85
Dynamic Interaction of Hsp90 with Its Client Protein p53
Park, S. J., Kostic, M., & Dyson, H. J. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.05.030 · Cited by 80
A fluorescence polarization assay for inhibitors of Hsp90
Howes, R., Barril, X., Dymock, B. W., Grant, K., Northfield, C. J., Robertson, A., Surgenor, A. E., Wayne, J., Wright, L., James, K. E., et al. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2005.12.023 · Cited by 84
In Vivo Conformational Dynamics of Hsp90 and Its Interactors
Chavez, J. D., Schweppe, D. K., Eng, J. K., & Bruce, J. E. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.05.012 · Cited by 82
Das, I., Basantray, I., Mamidi, P., Nayak, T. K., Pratheek, B. M., Chattopadhyay, S., & Chattopadhyay, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100531 · Cited by 85
Nakamoto, H., Fujita, K., Ohtaki, A., Watanabe, S., Narumi, S., Maruyama, T., Suenaga, E., Misono, T. S., Kumar, P. K. R., Goloubinoff, P., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.524801 · Cited by 78
Andrus, M. B., Meredith, E. L., Hicken, E. J., Simmons, B. L., Glancey, R. R., & Ma, W. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo034870l · Cited by 82
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
Gewirth, D. T. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160413141154 · Cited by 87
Synthesis and evaluation of geldanamycin–testosterone hybrids
Kuduk, S. D., Harris, C. R., Zheng, F. F., Sepp‐Lorenzino, L., Ouerfelli, O., Rosen, N. X., & Danishefsky, S. J. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00208-0 · Cited by 82
Natural heat shock protein 90 inhibitors in cancer and inflammation
Costa, T. E. M. M., Raghavendra, N. M., & Penido, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112063 · Cited by 82
Lübbers, T., Angehrn, P., Gmünder, H., Herzig, S., & Kulhanek, J. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00109-8 · Cited by 81
Raja, S. M., Clubb, R. J., Ortega-Cava, C. F., Williams, S. H., Bailey, T. A., Duan, L., Zhao, X., Reddi, A. L., Nyong, A. M., Natarajan, A., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.2.13959 · Cited by 81
Modulation of Hsf1 activity by novobiocin and geldanamycin
Condé, R., Belak, Z. R., Nair, M., O’Carroll, R. F., & Ovsenek, N. (2009) · Biochemistry and Cell Biology · doi:10.1139/o09-049 · Cited by 81
Gyrase B Inhibitor Impairs HIV-1 Replication by Targeting Hsp90 and the Capsid Protein
Vozzolo, L., Loh, B., Gane, P. J., Tribak, M., Zhou, L., Anderson, I., Nyakatura, E. K., Jenner, R. G., Selwood, D. L., & Fassati, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.155275 · Cited by 83
Cooperation of local motions in the Hsp90 molecular chaperone ATPase mechanism
Schulze, A., Beliu, G., Helmerich, D. A., Schubert, J., Pearl, L. H., Prodromou, C., & Neuweiler, H. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2111 · Cited by 84
Self-citationBagatell, R., Beliakoff, J., David, C. L., Marron, M. T., & Whitesell, L. J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20611 · Cited by 81
Jeon, Y. J., Kim, Y. K., Lee, M., Park, S. M., Han, S., & Kim, H. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39105-0 · Cited by 81
Small molecule modulators of protein-protein interactions: selected case studies
Aeluri, M., Chamakuri, S., Dasari, B., Guduru, S. K. R., Jimmidi, R., Jogula, S., & Arya, P. (2014) · Chemical Reviews · doi:10.1021/cr4004049 · Cited by 79
Targeting chaperones in transformed systems – a focus on Hsp90 and cancer
Chiosis, G. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.37 · Cited by 79
Structure-based discovery of a new class of Hsp90 inhibitors
Barril, X., Brough, P. A., Drysdale, M., Hubbard, R. E., Massey, A. J., Surgenor, A. E., & Wright, L. M. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.092 · Cited by 78
Won, Y.-W., Yoon, S.-M., Sonn, C. H., Lee, K., & Kim, Y. (2011) · ACS Nano · doi:10.1021/nn200173u · Cited by 78
hsp90 Is Required for Heme Binding and Activation of Apo-Neuronal Nitric-oxide Synthase
Billecke, S. S., Bender, A. T., Kanelakis, K. C., Murphy, P. J. M., Lowe, E. R., Kamada, Y., Pratt, W. B., & Osawa, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201940200 · Cited by 78
Cytosolic chaperones influence the fate of a toxin dislocated from the endoplasmic reticulum
Spooner, R. A., Hart, P. J., Cook, J., Pietroni, P., Rogon, C., Höhfeld, J., Roberts, L. M., & Lord, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809013105 · Cited by 77
Modular Asymmetric Synthesis of Aigialomycin D, a Kinase‐Inhibitory Scaffold
Barluenga, S., Dakas, P., Ferandin, Y., Meijer, L., & Winssinger, N. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600593 · Cited by 77
Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
Li, T., Jiang, H., Tong, Y., & Lu, J. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0602-8 · Cited by 80
Radicicol-sensitive Peptide Binding to the N-terminal Portion of GRP94
Vogen, S., Gidalevitz, T., Biswas, C., Simen, B. B., Stein, E., Gulmen, F., & Argon, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205323200 · Cited by 75
The Hsp90 chaperone machinery: from structure to drug development
Hahn, J. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.10.623 · Cited by 82
Shi, W., Xu, G., Zhan, X., Gao, Y., Wang, Z., Fu, S., Qin, N., Hou, X., Ai, Y., Wang, C., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2460-x · Cited by 78
Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance
Zhang, J., Li, H., Liu, Y., Zhao, K., Wei, S., Sugarman, E. T., Liu, L., & Zhang, G. (2022) · Cells · doi:10.3390/cells11182778 · Cited by 80
Crystal Structure of an Intact Type II DNA Topoisomerase: Insights into DNA Transfer Mechanisms
Graille, M., Cladière, L., Christiane, D. D., Lecointe, F., Gadelle, D., Quevillon‐Chéruel, S., Vachette, P., Forterre, P., & TILBEURGH, H. V. (2008) · Structure · doi:10.1016/j.str.2007.12.020 · Cited by 83
Anderson, J. F., Siller, E., & Barral, J. M. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.023 · Cited by 86
Inhibition of HSP90 in Trypanosoma cruzi Induces a Stress Response but No Stage Differentiation
Graefe, S. E. B., Wiesgigl, M., Gaworski, I., MacDonald, A., & Clos, J. (2002) · Eukaryotic Cell · doi:10.1128/ec.1.6.936-943.2002 · Cited by 76
Functional principles and regulation of molecular chaperones
Dahiya, V., & Buchner, J. (2019) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2018.10.001 · Cited by 76
Hsp90 as an anti-cancer target
Neckers, L., Mimnaugh, E. G., & Schulte, T. W. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0082 · Cited by 83
DNA relaxation and cleavage assays to study topoisomerase I inhibitors
Bailly, C. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)40445-9 · Cited by 76
Ligand Interactions in the Adenosine Nucleotide-binding Domain of the Hsp90 Chaperone, GRP94
Rosser, M. F. N., & Nicchitta, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001477200 · Cited by 76
Intrinsic Inhibition of the Hsp90 ATPase Activity
Richter, K., Moser, S., Hagn, F., Friedrich, R., Hainzl, O., Heller, M., Schlee, S., Kessler, H., Reinstein, J., & Buchner, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510142200 · Cited by 73
Kung, P., Huang, B., Zhang, G., Zhou, J. Z., Wang, J., Digits, J. A., Skaptason, J., Yamazaki, S., Neul, D., Zientek, M. A., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901209q · Cited by 75
Structure of Unliganded GRP94, the Endoplasmic Reticulum Hsp90
Dollins, D. E., Immormino, R. M., & Gewirth, D. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503761200 · Cited by 74
Dehner, A., Furrer, J., Richter, K., Schuster, I., Buchner, J., & Kessler, H. (2003) · ChemBioChem · doi:10.1002/cbic.200300658 · Cited by 75
Yamamoto, K., Garbaccio, R. M., Stachel, S. J., Solit, D. B., Chiosis, G., Rosen, N. X., & Danishefsky, S. J. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390329 · Cited by 75
Gu, M., Yu, Y., Gunaherath, G. M. K. B., Gunatilaka, A. A. L., Li, D., & Sun, D. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-9987-y · Cited by 91
Crystal structures of human HSP90α-complexed with dihydroxyphenylpyrazoles
Kreusch, A., Han, S., Brinker, A., Zhou, V. W., Choi, H.-S., He, Y., Lesley, S. A., Caldwell, J. S., & Gu, X.-J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.087 · Cited by 74
Hsp90—From signal transduction to cell transformation
Brown, M. A., Zhu, L., Schmidt, C., & Tucker, P. W. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.054 · Cited by 89
Li, Y., Tao, P., Liu, Y.-Z., & Jiang, J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.867-872.2004 · Cited by 73
Advances in the structures, mechanisms and targeting of molecular chaperones
Gu, J., He, Y., He, C., Zhang, Q., Huang, Q., Bai, S., Wang, R., You, Q., & Wang, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02166-2 · Cited by 84
Structure of the ATP‐binding domain of Plasmodium falciparum Hsp90
Corbett, K. D., & Berger, J. M. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22799 · Cited by 77
Glucocorticoid receptor dynamics and gene regulation
Biddie, S. C., & Hager, G. L. (2009) · Stress · doi:10.1080/10253890802506409 · Cited by 72
Immormino, R. M., Metzger, L. E., Reardon, P. N., Dollins, D. E., Blagg, B. S. J., & Gewirth, D. T. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.03.071 · Cited by 69
Plateau, P., Saveanu, C., Lestini, R., Dauplais, M., Decourty, L., Jacquier, A., Blanquet, S., & Lazard, M. (2017) · Scientific Reports · doi:10.1038/srep44761 · Cited by 75
Anti-inflammatory properties and pharmacological induction of Hsp70 after brain injury
Kim, N., Kim, J. Y., & Yenari, M. A. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0115-3 · Cited by 71
Willmund, F., & Schroda, M. (2005) · PLANT PHYSIOLOGY · doi:10.1104/pp.105.063578 · Cited by 76
Wainberg, Z. A., Anghel, A., Rogers, A. M., Desai, A. J., Kalous, O., Conklin, D. F., Ayala, R., O’Brien, N. A., Quadt, C., Akimov, M., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0507 · Cited by 70
BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy
Yin, X., Zhang, H., Lundgren, K., Wilson, L. D., Burrows, F. J., & Shores, C. G. (2009) · International Journal of Cancer · doi:10.1002/ijc.24815 · Cited by 70
Ghosh, A., Chawla‐Sarkar, M., & Stuehr, D. J. (2011) · The FASEB Journal · doi:10.1096/fj.10-180554 · Cited by 68
Cunningham, C. N., Southworth, D. R., Krukenberg, K. A., & Agard, D. A. (2012) · Protein Science · doi:10.1002/pro.2103 · Cited by 66
Yang, J., Yang, J., Iannone, M. A., Shih, W. J., Lin, Y., & Hait, W. N. (2001) · PubMed · Cited by 70
Localization of Sites of Interaction between p23 and Hsp90 in Solution
Martinez-Yamout, M. A., Venkitakrishnan, R. P., Preece, N. E., Kroon, G., Wright, P. E., & Dyson, H. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601759200 · Cited by 67
Andrus, M. B., Meredith, E. L., Simmons, B. L., Sekhar, B. B. V. S., & Hicken, E. J. (2002) · Organic Letters · doi:10.1021/ol0267432 · Cited by 69
Downregulation of the Hsp90 System Causes Defects in Muscle Cells of Caenorhabditis Elegans
Gaiser, A. M., Kaiser, C. J. O., Haslbeck, V., & Richter, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025485 · Cited by 77
Structure-based design of molecular cancer therapeutics
van Montfort, R. L. M., & Workman, P. (2009) · Trends in biotechnology · doi:10.1016/j.tibtech.2009.02.003 · Cited by 79
Divergent Syntheses of Resorcylic Acid Lactones: L‐783277, LL‐Z1640‐2, and Hypothemycin
Dakas, P., Jogireddy, R., Valot, G., Barluenga, S., & Winssinger, N. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200901373 · Cited by 67
Modular Asymmetric Synthesis of Pochonin C
Barluenga, S., López, P., Moulin, É., & Winssinger, N. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200454108 · Cited by 67
Sattin, S., Tao, J., Vettoretti, G., Moroni, E., Pennati, M., Lopergolo, A., Morelli, L., Bugatti, A., Zuehlke, A. D., Moses, M., et al. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201502211 · Cited by 69
Design, Synthesis, and Evaluation of a Radicicol and Geldanamycin Chimera, Radamide
Clevenger, R. C., & Blagg, B. S. J. (2004) · Organic Letters · doi:10.1021/ol048266o · Cited by 77
Radester, a Novel Inhibitor of the Hsp90 Protein Folding Machinery
Shen, G., & Blagg, B. S. J. (2005) · Organic Letters · doi:10.1021/ol050580a · Cited by 67
The Hsp90 Inhibitor Radicicol Interacts with the ATP-Binding Pocket of Bacterial Sensor Kinase PhoQ
Guarnieri, M. T., Zhang, L., Shen, J., & Zhao, R. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.036 · Cited by 67
Identification of the N-terminal Peptide Binding Site of Glucose-regulated Protein 94
Gidalevitz, T., Biswas, C., Ding, H., Schneidman‐Duhovny, D., Wolfson, H. J., Stevens, F. J., Radford, S. E., & Argon, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313060200 · Cited by 67
Mollapour, M., Tsutsumi, S., Kim, Y. S., Trepel, J., & Neckers, L. (2011) · Oncotarget · doi:10.18632/oncotarget.272 · Cited by 66
Piper, P. W., Millson, S. H., Mollapour, M., Panaretou, B., Siligardi, G., Pearl, L. H., & Prodromou, C. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03866.x · Cited by 64
Self-citationRadicicol Binds and Inhibits Mammalian ATP Citrate Lyase
Ki, S. W., Ishigami, K., Kitahara, T., Kasahara, K., Yoshida, M., & Horinouchi, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006192200 · Cited by 69
Proisy, N., Sharp, S. Y., Boxall, K. J., Connelly, S., Roe, S. M., Prodromou, C., Slawin, A. M. Z., Pearl, L. H., Workman, P., & Moody, C. J. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.015 · Cited by 66
Self-citationDymock, B. W., Barril, X., Beswick, M., Collier, A. J., Davies, N., Drysdale, M., Fink, A., Fromont, C., Hubbard, R. E., Massey, A. J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.11.011 · Cited by 68
Solution‐ and Solid‐Phase Synthesis of Radicicol (Monorden) and Pochonin C
Barluenga, S., Moulin, É., López, P., & Winssinger, N. (2005) · Chemistry - A European Journal · doi:10.1002/chem.200500160 · Cited by 65
The Hsp90 isoforms from S. cerevisiae differ in structure, function and client range
Girstmair, H., Tippel, F., Lopez, A., Tych, K., Stein, F., Haberkant, P., Schmid, P. W. N., Helm, D., Rief, M., Sattler, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11518-w · Cited by 62
Galigniana, M. D., Harrell, J. M., Housley, P. R., Patterson, C., Fisher, S. K., & Pratt, W. B. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.12.015 · Cited by 64
Xu, J., Jiang, C., Zhang, Z., Ma, W.-Q., & Guo, Y. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.155 · Cited by 64
Hsp90 as a Gatekeeper of Tumor Angiogenesis: Clinical Promise and Potential Pitfalls
Bohonowych, J. E., Gopal, U., & Isaacs, J. S. (2010) · Journal of Oncology · doi:10.1155/2010/412985 · Cited by 63
Hyperthermia Stimulates HIV-1 Replication
Roesch, F., Méziane, O., Kula, A., Nisole, S., Porrot, F., Anderson, I., Mammano, F., Fassati, A., Marcello, A., Benkirane, M., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002792 · Cited by 65
Radanyi, C., Bras, G. L., Marsaud, V., Peyrat, J., Messaoudi, S., CATELLI, M. G., Brion, J., Alami, M., & Renoir, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.09.001 · Cited by 67
Paul-Clark, M. J., Roviezzo, F., Flower, R. J., Cirino, G., Del Soldato, P., Adcock, I. M., & Perretti, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3245 · Cited by 66
Zubrienė, A., Matulienė, J., Baranauskienė, L., Jachno, J., Torresan, J., Michailovienė, V., Cimmperman, P., & Matulis, D. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10062662 · Cited by 63
Learning from Nature: Advances in Geldanamycin- and Radicicol-Based Inhibitors of Hsp90
Kitson, R. R. A., & Moody, C. J. (2013) · The Journal of Organic Chemistry · doi:10.1021/jo4002849 · Cited by 67
Pimienta, G., Herbert, K. M., & Regan, L. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200346y · Cited by 63
Bickel, D., & Gohlke, H. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115080 · Cited by 67
Metadata
- Authors
- Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H.
- Affiliations
- University College London (GB)
- Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, U.K.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-01-01
- Volume
- 42
- Issue
- 2
- Pages
- 260-266
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2042699875
- Cited by
- 1,004
- References
- 26
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 25 · 2023: 17 · 2022: 24 · 2021: 23 · 2020: 38 · 2019: 45 · 2018: 32 · 2017: 23 · 2016: 35 · 2015: 43 · 2014: 47 · 2013: 31 · 2012: 50
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- HSP90, molecular chaperones, geldanamycin, radicicol, antitumor antibiotics, ATPase inhibition, protein folding
- MeSH terms
- Adenosine Diphosphate, Adenosine Triphosphatases, Antibiotics, Antineoplastic, Calorimetry, Lactones, Models, Molecular, Quinones, Structure-Activity Relationship, Benzoquinones, Crystallography, X-Ray, Molecular Mimicry, HSP90 Heat-Shock Proteins, Macrolides, Lactams, Macrocyclic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.